A detailed history of Profit Investment Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Profit Investment Management, LLC holds 68,001 shares of VKTX stock, worth $4.68 Million. This represents 3.37% of its overall portfolio holdings.

Number of Shares
68,001
Previous 100,223 32.15%
Holding current value
$4.68 Million
Previous $5.31 Million 18.96%
% of portfolio
3.37%
Previous 3.31%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$49.84 - $70.47 $1.61 Million - $2.27 Million
-32,222 Reduced 32.15%
68,001 $4.31 Million
Q2 2024

Jul 12, 2024

BUY
$47.39 - $80.2 $196,289 - $332,188
4,142 Added 4.31%
100,223 $5.31 Million
Q1 2024

Apr 11, 2024

SELL
$17.4 - $94.5 $1.58 Million - $8.58 Million
-90,841 Reduced 48.6%
96,081 $7.88 Million
Q4 2023

Jan 12, 2024

BUY
$9.24 - $19.64 $1.73 Million - $3.67 Million
186,922 New
186,922 $3.48 Million

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.28B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Profit Investment Management, LLC Portfolio

Follow Profit Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profit Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profit Investment Management, LLC with notifications on news.